申请人:Osaka University
公开号:EP3804759A1
公开(公告)日:2021-04-14
The present invention found that, for example, inhibiting phosphorylation of a Ser residue in Regnase-1 is effective in treating and/or preventing diseases. The invention also found that, for example, inhibiting the binding of Regnase-1 with at least one factor selected from the group consisting of TBK1, IKKi, Act-1, IKK, and IRAK is effective in treating and/or preventing diseases.
本发明发现,例如,抑制 Regnase-1 中 Ser 残基的磷酸化可有效治疗和/或预防疾病。本发明还发现,例如,抑制 Regnase-1 与至少一种选自 TBK1、IKKi、Act-1、IKK 和 IRAK 所组成的组的因子的结合可有效治疗和/或预防疾病。